FCN2 and liver cancer: Notably, over-expression of the serum protein ficolin-2 was proven to significantly reduce the migratory and invasive behavior of liver cancer cells in vitro and in vivo, attenuating the epithelial-mesenchymal transition via stimulation of the TGFβ/Smad transduction pathway (Yang et al., 2016[74]).